|
|
|
|
|
Delaware
|
|
001-36296
|
|
26-2025616
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|||
245 First Street, Suite 1800
Cambridge, MA
|
|
02142
|
||
(Address of principal executive offices)
|
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a–12 under the Exchange Act (17 CFR 240.14a–12)
|
¨
|
Pre–commencement communications pursuant to Rule 14d–2(b) under the Exchange Act (17 CFR 240.14d–2(b))
|
¨
|
Pre–commencement communications pursuant to Rule 13e–4(c) under the Exchange Act (17 CFR 240.13e–4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001
|
SESN
|
The Nasdaq Stock Market LLC
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
a)
|
The following nominee was elected to the Company’s Board of Directors (the "Board") as a class III director, for a three-year term ending at the annual meeting of stockholders to be held in 2023 and until her successor has been duly elected and qualified, and received the number of votes as follows:
|
Name
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
Jane V. Henderson
|
|
38,960,135
|
|
0
|
|
4,952,691
|
|
38,257,787
|
b)
|
The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2020 was approved based on the following number of votes:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
77,107,975
|
|
3,650,318
|
|
1,412,320
|
|
0
|
c)
|
The proposal to approve, by non-binding advisory vote, the compensation of the Company's named executive officers was approved based on the following number of votes:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
31,030,045
|
|
11,761,467
|
|
1,121,314
|
|
38,257,787
|
d)
|
The proposal to approve, by non-binding advisory vote, the frequency of future votes to approve the compensation of the Company's named executive officers received the following votes:
|
One Year
|
|
Two Years
|
|
Three Years
|
|
Abstentions
|
|
Broker Non-Votes
|
38,823,844
|
|
1,494,057
|
|
1,650,791
|
|
1,944,134
|
|
38,257,787
|
|
|
|
Sesen Bio, Inc.
|
||
|
|
|
By:
|
|
/s/ Thomas R. Cannell, D.V.M.
|
|
|
Thomas R. Cannell, D.V.M.
|
|
|
President and Chief Executive Officer
|